A Phase I Study of Intravenous (IV) Calcitriol in Combination With ZD1839 (IRESSA) in Refractory Solid Tumors
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Calcitriol (Primary) ; Dexamethasone; Gefitinib
- Indications Solid tumours
- Focus Adverse reactions
- 13 Jan 2014 Biomarkers information updated
- 27 Sep 2010 Actual end date (May 2007) added as reported by ClinicalTrials.gov.
- 27 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.